Cargando…

Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli

BACKGROUND: Natural glycolysis encounters the decarboxylation of glucose partial oxidation product pyruvate into acetyl-CoA, where one-third of the carbon is lost at CO(2). We previously constructed a carbon saving pathway, EP-bifido pathway by combining Embden-Meyerhof-Parnas Pathway, Pentose Phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Xian, He, Xu, Ya, Zhu, Yuan, Sun, Zhijie, Wang, Qian, Qi, Qingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852082/
https://www.ncbi.nlm.nih.gov/pubmed/33531004
http://dx.doi.org/10.1186/s12934-021-01526-1
_version_ 1783645748589494272
author Li, Ying
Xian, He
Xu, Ya
Zhu, Yuan
Sun, Zhijie
Wang, Qian
Qi, Qingsheng
author_facet Li, Ying
Xian, He
Xu, Ya
Zhu, Yuan
Sun, Zhijie
Wang, Qian
Qi, Qingsheng
author_sort Li, Ying
collection PubMed
description BACKGROUND: Natural glycolysis encounters the decarboxylation of glucose partial oxidation product pyruvate into acetyl-CoA, where one-third of the carbon is lost at CO(2). We previously constructed a carbon saving pathway, EP-bifido pathway by combining Embden-Meyerhof-Parnas Pathway, Pentose Phosphate Pathway and “bifid shunt”, to generate high yield acetyl-CoA from glucose. However, the carbon conversion rate and reducing power of this pathway was not optimal, the flux ratio of EMP pathway and pentose phosphate pathway (PPP) needs to be precisely and dynamically adjusted to improve the production of mevalonate (MVA). RESULT: Here, we finely tuned the glycolytic flux ratio in two ways. First, we enhanced PPP flux for NADPH supply by replacing the promoter of zwf on the genome with a set of different strength promoters. Compared with the previous EP-bifido strains, the zwf-modified strains showed obvious differences in NADPH, NADH, and ATP synthesis levels. Among them, strain BP10BF accumulated 11.2 g/L of MVA after 72 h of fermentation and the molar conversion rate from glucose reached 62.2%. Second, pfkA was finely down-regulated by the clustered regularly interspaced short palindromic repeats interference (CRISPRi) system. The MVA yield of the regulated strain BiB1F was 8.53 g/L, and the conversion rate from glucose reached 68.7%. CONCLUSION: This is the highest MVA conversion rate reported in shaken flask fermentation. The CRISPRi and promoter fine-tuning provided an effective strategy for metabolic flux redistribution in many metabolic pathways and promotes the chemicals production.
format Online
Article
Text
id pubmed-7852082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78520822021-02-03 Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli Li, Ying Xian, He Xu, Ya Zhu, Yuan Sun, Zhijie Wang, Qian Qi, Qingsheng Microb Cell Fact Research BACKGROUND: Natural glycolysis encounters the decarboxylation of glucose partial oxidation product pyruvate into acetyl-CoA, where one-third of the carbon is lost at CO(2). We previously constructed a carbon saving pathway, EP-bifido pathway by combining Embden-Meyerhof-Parnas Pathway, Pentose Phosphate Pathway and “bifid shunt”, to generate high yield acetyl-CoA from glucose. However, the carbon conversion rate and reducing power of this pathway was not optimal, the flux ratio of EMP pathway and pentose phosphate pathway (PPP) needs to be precisely and dynamically adjusted to improve the production of mevalonate (MVA). RESULT: Here, we finely tuned the glycolytic flux ratio in two ways. First, we enhanced PPP flux for NADPH supply by replacing the promoter of zwf on the genome with a set of different strength promoters. Compared with the previous EP-bifido strains, the zwf-modified strains showed obvious differences in NADPH, NADH, and ATP synthesis levels. Among them, strain BP10BF accumulated 11.2 g/L of MVA after 72 h of fermentation and the molar conversion rate from glucose reached 62.2%. Second, pfkA was finely down-regulated by the clustered regularly interspaced short palindromic repeats interference (CRISPRi) system. The MVA yield of the regulated strain BiB1F was 8.53 g/L, and the conversion rate from glucose reached 68.7%. CONCLUSION: This is the highest MVA conversion rate reported in shaken flask fermentation. The CRISPRi and promoter fine-tuning provided an effective strategy for metabolic flux redistribution in many metabolic pathways and promotes the chemicals production. BioMed Central 2021-02-02 /pmc/articles/PMC7852082/ /pubmed/33531004 http://dx.doi.org/10.1186/s12934-021-01526-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Ying
Xian, He
Xu, Ya
Zhu, Yuan
Sun, Zhijie
Wang, Qian
Qi, Qingsheng
Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title_full Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title_fullStr Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title_full_unstemmed Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title_short Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli
title_sort fine tuning the glycolytic flux ratio of ep-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (zwf) and crispri suppressing 6-phosphofructose kinase (pfka) in escherichia coli
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852082/
https://www.ncbi.nlm.nih.gov/pubmed/33531004
http://dx.doi.org/10.1186/s12934-021-01526-1
work_keys_str_mv AT liying finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT xianhe finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT xuya finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT zhuyuan finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT sunzhijie finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT wangqian finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli
AT qiqingsheng finetuningtheglycolyticfluxratioofepbifidopathwayformevalonateproductionbyenhancingglucose6phosphatedehydrogenasezwfandcrisprisuppressing6phosphofructosekinasepfkainescherichiacoli